Bleeding diathesis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
{| class="wikitable"
{| class="wikitable"
|+
|+
!
! rowspan="2" |Category
!
! rowspan="2" |Sub-category
!
! rowspan="2" |Diseases
!
! rowspan="2" |
! rowspan="2" |History
! rowspan="2" |History
! colspan="5" |Clinical manifestation
! colspan="5" |Clinical manifestation
! colspan="5" |Laboratory testing
! colspan="5" |Laboratory testing
|-
|-
!
!
!
!
!'''Petechiae'''
!'''Petechiae'''
!'''Ecchymoses'''  
!'''Ecchymoses'''  
Line 36: Line 32:
| rowspan="15" |Platelet disorders
| rowspan="15" |Platelet disorders
| rowspan="7" |'''Thrombocytopenia'''
| rowspan="7" |'''Thrombocytopenia'''
|Infection-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span>
|[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span>
|
|
|
|
Line 50: Line 46:
|
|
|-
|-
|Drug-Induced Thrombocytopenia<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>
|[[Medication|Medications]]-Induced Thrombocy<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>topenia
|
|
|
|
Line 64: Line 60:
|
|
|-
|-
|Heparin-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span>
|[[Heparin]]-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span>
|
|
|
|
Line 78: Line 74:
|
|
|-
|-
|Immune Thrombocytopenic Purpura (ITP)<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span>
|[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span>
|
|
|
|
Line 106: Line 102:
|
|
|-
|-
|Thrombotic Thrombocytopenic Purpura (TTP)<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span>
|[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span>
|
|
|
|
Line 120: Line 116:
|
|
|-
|-
|Hemolytic Uremic Syndrome<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span>
|[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span>
|
|
|
|
Line 149: Line 145:
|
|
|-
|-
| rowspan="7" |Qualitative Disorders of Platelet Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
| rowspan="7" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|Inherited Disorders of Platelet Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span>
|
|
|
|
Line 164: Line 160:
|
|
|-
|-
|Acquired Disorders of Platelet Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span>
|Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span>
|
|
|
|
Line 178: Line 174:
|
|
|-
|-
| rowspan="5" |von Willebrand Disease<span name="harr_c115s002s005p001"></span><span name="9100810"></span>
| rowspan="5" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span>
|Type 1
|Type 1
|
|
Line 291: Line 287:
|
|
|-
|-
|Prothrombin deficiency
|[[Prothrombin deficiency]]
|
|
|
|
Line 306: Line 302:
|
|
|-
|-
| rowspan="1" |Factor V deficiency
| rowspan="1" |[[Factor V deficiency]]
|
|
|
|
Line 321: Line 317:
|
|
|-
|-
| rowspan="1" |Factor VII deficiency
| rowspan="1" |[[Factor VII deficiency]]
|
|
|
|
Line 336: Line 332:
|
|
|-
|-
| rowspan="1" |Factor VIII deficiency
| rowspan="1" |[[Factor VIII deficiency]]
|
|
|
|
Line 366: Line 362:
|
|
|-
|-
| rowspan="1" |Factor X deficiency
| rowspan="1" |[[Factor X deficiency]]
|
|
|
|
Line 381: Line 377:
|
|
|-
|-
| rowspan="1" |Factor XI deficiency
| rowspan="1" |[[Factor XI|Factor XI deficiency]]
|
|
|
|
Line 396: Line 392:
|
|
|-
|-
| rowspan="1" |Factor XII deficiency
| rowspan="1" |[[Factor XII|Factor XII deficiency]]
|
|
|
|
Line 426: Line 422:
|
|
|-
|-
| rowspan="1" |Prekallikrein deficiency
| rowspan="1" |[[Prekallikrein]] deficiency
|
|
|
|
Line 441: Line 437:
|
|
|-
|-
| rowspan="1" |Factor XIII deficiency
| rowspan="1" |[[Factor XIII deficiency]]
|
|
|
|
Line 503: Line 499:
|-
|-
| rowspan="4" |Rare diseases
| rowspan="4" |Rare diseases
|Disseminated Intravascular Coagulation
|[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]]
|
|
|
|
Line 518: Line 514:
|
|
|-
|-
|Vitamin K Deficiency
|[[Vitamin K Deficiency]]
|
|
|
|
Line 533: Line 529:
|
|
|-
|-
|Coagulation Disorders Associated with Liver Failure
|Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]]
|
|
|
|

Revision as of 16:47, 22 August 2018


Bleeding diathesis main page

Overview

Classification

Differential Diagnosis

Platelet disorders
Immune Thrombocytopenic Purpura
Thrombotic Thrombocytopenic Purpura
Hemolytic Uremic Syndrome
Thrombocytosis
Von Willebrand Disease
Coagulation disorders
Fibrinogen deficiency
Prothrombin deficiency
Factor V deficiency
Factor VII deficiency
Factor VIII deficiency
Factor IX deficiency
Factor X deficiency
Factor XI deficiency
Factor XII deficiency
High-molecular-weight kininogen deficiency
Prekallikrein deficiency
Factor XIII deficiency
Hemophilia
Rare diseases
Disseminated Intravascular Coagulation
Vitamin K Deficiency

Different types of Von-Willebrand diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]

Overview

Classification

Differential Diagnosis

Category Sub-category Diseases History Clinical manifestation Laboratory testing
Petechiae Ecchymoses Menorrhagia Hematomas Hemarthrosis platelet count Bleeding time (BT) Prothrombin time (PT) Platelet count activated partial thromboplastin time (aPTT) Thrombin time (TT)
Platelet disorders Thrombocytopenia Infection-Induced Thrombocytopenia
Medications-Induced Thrombocytopenia
Heparin-Induced Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Inherited Thrombocytopenia
Thrombotic Thrombocytopenic Purpura (TTP)
Hemolytic Uremic Syndrome
Thromobcytosis Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal.
Qualitative Disorders of Platelet Function Inherited Disorders of Platelet Function
Acquired Disorders of Platelet Function
Von Willebrand Disease Type 1
Type 2 A
Type 2 B
Type 2 M
Type 3
Vessel wall disorders Metabolic and Inflammatory Disorders
Inherited Disorders of the Vessel Wall
Coagulation disorders Fibrinogen deficiency
Prothrombin deficiency
Factor V deficiency
Factor VII deficiency
Factor VIII deficiency
Factor IX deficiency
Factor X deficiency
Factor XI deficiency
Factor XII deficiency
HK deficiency
Prekallikrein deficiency
Factor XIII deficiency
Hemophilia Type A deficiency
Type B deficiency
Type C deficiency
Rare diseases Disseminated Intravascular Coagulation
Vitamin K Deficiency
Coagulation Disorders Associated with Liver Failure
Acquired Inhibitors of Coagulation Factors